Filing Details

Accession Number:
0001658918-26-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2026-07-17 21:46:47
Reporting Period:
2026-07-15
Filing Date:
2026-07-17
Accepted Time:
2026-07-17 21:46:47
SEC Url:
Form 4 Filing
10b5-1 trading plan:
Unchecked
Issuer
Cik Name Symbol Sector (SIC) IRS No
1770069 Maplight Therapeutics Inc. MPLT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658918 A. Christopher Kroeger C/O Maplight Therapeutics, Inc.
800 Chesapeake Drive
Redwood City CA 94063
Chief Executive Officer No No No No
Transaction Summary
Sold: 147,639 shares Avg. Price: $36.87 Total Value: $5,443,721.84
Number of Shares After Transactions: 1,246,455 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Disposition 2026-07-15 18,950 $36.00 1,375,144 No 4 S Direct
Voting Common Stock Disposition 2026-07-15 42,738 $36.99 1,332,406 No 4 S Direct
Voting Common Stock Disposition 2026-07-15 90 $37.54 1,332,316 No 4 S Direct
Voting Common Stock Disposition 2026-07-16 40,899 $36.46 1,291,417 No 4 S Direct
Voting Common Stock Disposition 2026-07-16 28,091 $37.26 1,263,326 No 4 S Direct
Voting Common Stock Disposition 2026-07-16 92 $37.96 1,263,234 No 4 S Direct
Voting Common Stock Disposition 2026-07-17 16,779 $37.90 1,246,455 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Voting Common Stock 101,190 Indirect See footnote
Footnotes
  1. Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.